Machine learning for grading prediction and survival analysis in high grade glioma.

Journal: Scientific reports
PMID:

Abstract

We developed and validated a magnetic resonance imaging (MRI)-based radiomics model for the classification of high-grade glioma (HGG) and determined the optimal machine learning (ML) approach. This retrospective analysis included 184 patients (59 grade III lesions and 125 grade IV lesions). Radiomics features were extracted from MRI with T1-weighted imaging (T1WI). The least absolute shrinkage and selection operator (LASSO) feature selection method and seven classification methods including logistic regression, XGBoost, Decision Tree, Random Forest (RF), Adaboost, Gradient Boosting Decision Tree, and Stacking fusion model were used to differentiate HGG. Performance was compared on AUC, sensitivity, accuracy, precision and specificity. In the non-fusion models, the best performance was achieved by using the XGBoost classifier, and using SMOTE to deal with the data imbalance to improve the performance of all the classifiers. The Stacking fusion model performed the best, with an AUC = 0.95 (sensitivity of 0.84; accuracy of 0.85; F1 score of 0.85). MRI-based quantitative radiomics features have good performance in identifying the classification of HGG. The XGBoost method outperforms the classifiers in the non-fusion model and the Stacking fusion model outperforms the non-fusion model.

Authors

  • Xiangzhi Li
    Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Branch of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No.50, Zhenxin Road, Taizhou, 317502, China.
  • Xueqi Huang
    School of Science & School of Medicine, Guangxi University of Science and Technology, Liuzhou, 545006, China.
  • Yi Shen
    Department of Oral Maxillofacial-Head Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China. Electronic address: shenyi_777@126.com.
  • Sihui Yu
    Department of Radiology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • Lin Zheng
    Department of Minimally Invasive Intervention, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, 450008, China.
  • Yunxiang Cai
    Department of Clinical Laboratory, The First Affiliated Hospital of Huzhou University, The First People's Hospital of Huzhou City, Zhejiang Province, China.
  • Yang Yang
    Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Renyuan Zhang
    Department of International Education College, Hainan Medical University, Haikou, 571199, China.
  • Lingying Zhu
    Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Branch of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, 317502, Zhejiang, China. whitemouse811@hotmail.com.
  • Enyu Wang
    Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence, Taizhou Branch of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), Taizhou, 317502, Zhejiang, China.